Diabetes Care Devices are used in the treatment and management of diabetes. Insulin Delivery Devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. An Insulin Pen is used to inject insulin for the treatment of diabetes. GlobalData uses proprietary data and analytics to provide a comprehensive report on the insulin pens devices market, including market shares of different players within Belgium. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the insulin pens market in Belgium was Sanofi followed by Eli Lilly and Co and Novo Nordisk.
An Insulin Pen is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. Both Disposable and Reusable Insulin Pens are included. Disposable Pens include an insulin cartridge, a dial to measure dosage, and a disposable needle. Reusable Insulin-Delivery Pens require the patient to load insulin cartridges into the pen.
The value of the insulin pens devices market within Belgium was expected to be over $30m in 2023.
For the latest complete market share analysis of insulin pens device market in Belgium, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
